小儿消积止咳口服液联合孟鲁司特钠和特布他林治疗儿童慢性咳嗽变异性哮喘的临床研究

中华养生保健 ›› 2023, Vol. 41 ›› Issue (23): 31-34.

小儿消积止咳口服液联合孟鲁司特钠和特布他林治疗儿童慢性咳嗽变异性哮喘的临床研究

顾芙蓉¹, 范海婷^2,*

1.南京市江宁中医院儿科,江苏南京,211100;
2.盐城德馨医院药剂科,江苏盐城,224001

出版日期:2023-12-01 发布日期:2023-11-21
通讯作者: ^*范海婷,E-mail：925837689@qq.com。
作者简介:顾芙蓉（1985—）,女,汉族,籍贯：江苏省盐城市,本科,主治医师,研究方向：儿童呼吸疾病。

Clinical Study on Pediatric Xiaoer Xiaoji Cough Oral Liquid Combined with Montelukast Sodium and Terbutaline in the Treatment of Chronic Cough Variant Asthma in Children

GU Fu-rong¹, FAN Hai-ting^2,*

1. Department of Pediatrics, Jiangning Traditional Chinese Medicine Hospital, Nanjing Jiangsu 211100, China;
2. Pharmacy Department of Yancheng Dexin Hospital, Yancheng Jiangsu 224001, China

Online:2023-12-01 Published:2023-11-21

摘要/Abstract

摘要： 目的观察小儿消积止咳口服液联合孟鲁司特钠和特布他林治疗儿童慢性咳嗽变异性哮喘（cough variant asthma,CVA）的临床疗效。方法选取2018年1月—2022年1月60例在南京市江宁区中医院儿科门诊、住院的CVA患儿,按照随机数表法分为治疗组和对照组,每组30例,对照组给予雾化特布他林、口服孟鲁司特钠咀嚼片,治疗组在对照组治疗基础上给予口服小儿消积止咳口服液,3次/d,15~20 mL/次,将连续治疗14 d临床疗效、不良事件发生率记录整理数据并统计分析。结果治疗后治疗组患儿嗜酸性粒细胞（EOS）、超敏C反应蛋白（hs-CRP）水平均明显低于对照组,差异有统计学意义（P<0.05）;治疗后治疗组患儿的咳嗽缓解时间短于对照组,差异有统计学意义（P<0.05）;治疗组治疗有效率高于对照组,差异有统计学意义（P<0.05）;两组患儿在治疗过程中不良事件的发生率比较,差异无统计学意义（P>0.05）。结论小儿消积止咳口服液联合孟鲁司特钠和特布他林治疗儿童CVA,可以更有效地降低血液炎性指标,更快地改善咳嗽症状,治疗过程中的不良事件发生率未升高,值得临床应用。

关键词: 小儿消积止咳口服液, 孟鲁司特钠, 特布他林, 儿童慢性咳嗽变异性哮喘

Abstract: Objective To observe the clinical effect of xiaoer Xiaoji cough oral liquid combined with Montelukast sodium and Terbutaline in the treatment of chronic cough variant asthma CVA in children. Methods From January 2018 to December 2022, sixty patients with CVA were selected and randomly divided into treatment group and control group, with 30 Datients in each group. The control group was given atomized terbutaline, oral Montelukast sodium chewable tablets. On the basis of control group, xiaoer Xiaoji cough oral liquid was added to the treatment group, 3 times/day, 15~20 mL/time, for 14 consecutive days. The percentage of eosinophil granulosis (EOS), the level of hypersensitive C-reactive protein (hs-CRP), the duration of cough remission, clinical efficacy, and the incidence of adverse events were recorded and statistically analyzed before and after treatment. Results After treatment, EOS and hs-CRP in the treatment group were significantly lower than those in the control group (P<0.05). After treatment, the remission time of cough in treatment group was shorter than that in control group, and the difference was statistically significant (P<0.05). The effective rate of treatment group was higher than control group, and the difference was statistically significant (P<0.05). There was no significant difference in the incidence of adverse events between the two groups (P>0.05). Conclusion Pediatric xiaoer Xiaoji cough oral liquid combined with Montelukast sodium and Terbutaline in the treatment of children's CVA can more effectively reduce blood inflammation indicators, improve cough symptoms faster, the incidence of adverse events during the treatment process did not increase, which is worthy of further clinical recommendation.

Key words: Xiaoer Xiaoji cough oral liquid, montelukast sodium, terbutaline, cough variant asthma in children

中图分类号:

R725.6

顾芙蓉, 范海婷. 小儿消积止咳口服液联合孟鲁司特钠和特布他林治疗儿童慢性咳嗽变异性哮喘的临床研究[J]. 中华养生保健, 2023, 41(23): 31-34.

GU Fu-rong, FAN Hai-ting. Clinical Study on Pediatric Xiaoer Xiaoji Cough Oral Liquid Combined with Montelukast Sodium and Terbutaline in the Treatment of Chronic Cough Variant Asthma in Children[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(23): 31-34.

参考文献

[1] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.支气管哮喘基层诊疗指南(2018年)[J].中华全科医学杂志,2018,17(10):751-762.
[2] 中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(2015)[J].中华结核和呼吸杂志,2016,39(5):323-340.
[3] 张钰,张丽珍,申永旺,等.呼出气一氧化氮浓度、诱导痰嗜酸粒细胞分数及二者联合对咳嗽变异性哮喘与感染后咳嗽所致儿童慢性咳嗽的鉴别诊断价值[J].实用心脑肺血管病杂志,2020,28(1):88-91.
[4] 姜永红,姜之炎,肖臻,等.PC-QoL问卷评价中药联合耳穴治疗对1~6岁慢性咳嗽患儿生活质量的影响[J].现代中西医结合杂志,2021,30(5):457-462.
[5] CORRAOWM. Pearls and pitfalls in the diagnosis of cough variant asthma[J]. Allergy Asthma Proc,2018,39(6):466-467.
[6] 赵嘉虹,阚璇.儿童咳嗽变异性哮喘发病机制及诊治进展[J].国际儿科学杂志,2022,49(2):96-99.
[7] 中华医学会儿科学分会呼吸学组慢性咳嗽协助组,中国儿童慢性咳嗽诊断与治疗指南(2013年修订)[J].中华儿科杂志,2014,52(3):184-188.
[8] 徐炎景,田英娜,田京辉.小儿消积止咳口服液联合阿奇霉素治疗儿童支原体肺炎临床研究[J].新中医,2022,54(24):124-127.
[9] JEREMY A.O'SULLIVAN, BRUCES. BOCHNER,王子熹.嗜酸性粒细胞及嗜酸性粒细胞相关疾病研究进展[J].中华临床免疫和变态反应杂志,2018,12(3):360-372.
[10] 吴宏图,丁娴,张磊,等.儿童咳嗽变异性哮喘FeNO、hs-CRP及IgE水平变化及意义[J].山东大学学报(医学版),2014,52(z2):82-83.
[11] URYASJEV M O, PONOMAREVA I V, BHAR M, et al.The cough variant asthma[J].Ter Arkh,2020,92(3):98-101.
[12] 扎依旦·艾力,阿布来提·阿不都哈尔.糖皮质激素治疗对细支气管炎患儿长期生长发育的影响[J].中国当代儿科杂志,2022,24(3):261-265.
[13] 陈志斌. 晁恩祥教授辨治风咳学术经验及临证特色[J].福建中医药,2017,48(4):53-54.
[14] 苏贵灵,张先来,王佐,等.小儿消积止咳口服液联合常规药物治疗小儿支气管哮喘的疗效[J].临床药物治疗杂志,2022,20(9):72-76.
[15] 刘莎,刘芳君,符州,等.气道反应性测定在婴幼儿咳嗽变异性哮喘诊断中的价值[J].中华实用儿科临床杂志,2020,35(21):1624-1628.